Currently, consistent effects have been demonstrated with 5-HT6R antagonists in preclinical models of cognition, and the role of these receptors in depression and anxiety has also been postulated although the majority of 5-HT6R in vivo research has focused on their pro-cognitive effects. The gene discussed is HTR6; the disease is major depressive disorder.